Literature DB >> 14535979

Simplified 13C-urea breath test with a new infrared spectrometer for diagnosis of Helicobacter pylori infection.

Tseng-Shing Chen1, Full-Young Chang, Pang-Chi Chen, Thomas W Huang, Jonathan T Ou, Ming-Hung Tsai, Ming-Shiang Wu, Jaw-Town Lin.   

Abstract

BACKGROUND AND AIM: Infrared spectrometry has correlated excellently with mass spectrometry in detecting the ratio of 13CO(2) to 12CO(2) in breath samples. The present study aimed to evaluate the accuracy of the 13C-urea breath test (13C-UBT) using a new model of infrared analyzer.
METHODS: A total of 600 patients who were undergoing upper endoscopy without receiving eradication therapy were entered into the study. Culture, histology, and rapid urease test on biopsies from the antrum and corpus of the stomach were used for the determination of Helicobacter pylori infection. Breath samples were collected before and 20 min after drinking 100 mg 13C-urea in 100 mL water. The optimal cutoff value was determined by the receiver operating characteristic curve.
RESULTS: Of the 586 patients who were eligible for analysis, 369 were positive for H. pylori infection, 185 were negative for H. pylori infection, and 32 were indeterminate. When the appropriate cutoff value was set at 3.5 per thousand, a sensitivity of 97.8%, a specificity of 96.8% and an accuracy of 97.5% were obtained using the 13C-UBT. The accuracy of the 13C-UBT decreased when CO(2) concentration in the breath sample was <2%, as compared with > or = 2% (93.6%vs 97.7%), mainly because of a decrease in specificity (81.8%vs 97.7%). There were 2.7% of patients with Delta13CO(2) values that fell between 3.0-4.5 per thousand, in whom the risk of error was 47%.
CONCLUSIONS: The 13C-UBT performed with infrared spectrometry is a highly sensitive, specific, and non-invasive method for the detection of H. pylori infection. The immediate availability of the test result and technical simplicity make it particularly effective in routine clinical practice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14535979     DOI: 10.1046/j.1440-1746.2003.03139.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

Review 1.  Accuracy of urea breath test in Helicobacter pylori infection: meta-analysis.

Authors:  Mazen Ferwana; Imad Abdulmajeed; Ali Alhajiahmed; Wedad Madani; Belal Firwana; Rim Hasan; Osama Altayar; Paul J Limburg; Mohammad Hassan Murad; Bandar Knawy
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

Review 2.  Update on diagnostic value of breath test in gastrointestinal and liver diseases.

Authors:  Imran Siddiqui; Sibtain Ahmed; Shahab Abid
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

Review 3.  Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

4.  An optimized 13C-urea breath test for the diagnosis of H pylori infection.

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

Review 5.  Carbon-13 urea breath test for Helicobacter pylori infection in patients with uninvestigated ulcer-like dyspepsia: an evidence-based analysis.

Authors:  D Ling
Journal:  Ont Health Technol Assess Ser       Date:  2013-10-01

6.  Cut-off optimization for 13C-urea breath test in a community-based trial by mathematic, histology and serology approach.

Authors:  Zhe-Xuan Li; Lei-Lei Huang; Cong Liu; Luca Formichella; Yang Zhang; Yu-Mei Wang; Lian Zhang; Jun-Ling Ma; Wei-Dong Liu; Kurt Ulm; Jian-Xi Wang; Lei Zhang; Monther Bajbouj; Ming Li; Michael Vieth; Michael Quante; Tong Zhou; Le-Hua Wang; Stepan Suchanek; Erwin Soutschek; Roland Schmid; Meinhard Classen; Wei-Cheng You; Markus Gerhard; Kai-Feng Pan
Journal:  Sci Rep       Date:  2017-05-18       Impact factor: 4.379

7.  Helicobacter pylori infection with intestinal metaplasia: An independent risk factor for colorectal adenomas.

Authors:  Ye Yan; Yi-Na Chen; Qian Zhao; Chao Chen; Chun-Jing Lin; Yin Jin; Shuang Pan; Jian-Sheng Wu
Journal:  World J Gastroenterol       Date:  2017-02-28       Impact factor: 5.742

Review 8.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15

9.  Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial.

Authors:  Jyh-Ming Liou; Chieh-Chang Chen; Chi-Yang Chang; Mei-Jyh Chen; Chien-Chuan Chen; Yu-Jen Fang; Ji-Yuh Lee; Tsung-Hua Yang; Jiing-Chyuan Luo; Jeng-Yih Wu; Tai-Cherng Liou; Wen-Hsiung Chang; Yao-Chun Hsu; Cheng-Hao Tseng; Chun-Chao Chang; Ming-Jong Bair; Tzeng-Ying Liu; Chun-Fu Hsieh; Feng-Yun Tsao; Chia-Tung Shun; Jaw-Town Lin; Yi-Chia Lee; Ming-Shiang Wu
Journal:  Gut       Date:  2015-09-03       Impact factor: 23.059

10.  Correlation Analysis Among Genotype Resistance, Phenotype Resistance, and Eradication Effect After Resistance-Guided Quadruple Therapies in Refractory Helicobacter pylori Infections.

Authors:  Zijun Guo; Shuxin Tian; Weijun Wang; Yanbin Zhang; Jing Li; Rong Lin
Journal:  Front Microbiol       Date:  2022-03-07       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.